| 7 |
Limbach Group adopts QuantaMatrix dRASTTM in routine clinical use
|
|
2021-12-15 |
| 6 |
QuantaMatrix, Applied for an Export License from the Korean Ministry of Food and Drug Safety for the COVID-19 Molecular Diagnostic Kit
|
|
2020-12-21 |
| 5 |
QuantaMatrix to Debut on KOSDAQ on Wednesday (12/9) as IPO prices at $23.57 high end, raising $40.2mn
|
|
2020-12-09 |
| 4 |
QuantaMatrix installs 12 dRAST Platforms - direct Rapid Antimicrobial Susceptibility Testing - in ten European Countries
|
Download
|
2020-08-26 |
| 3 |
QuantaMatrix, Early Diagnosis Kit for Alzheimer's Disease Approved by the Ministry of Food and Drug Safety
|
|
2020-07-21 |
| 2 |
QuantaMatrix Passes Preliminary Review for KOSDAQ Listing
|
|
2020-06-26 |
| 1 |
QuantaMatrix Passes Technical Assessment, Accelerating Preparation for Listing in KOSDAQ
|
|
2019-12-18 |
Login